Description

• Foresite Labs primarily supports idea formation through early company building, helping founders and scientific entrepreneurs take concepts to funded startup ventures. 
  
  
• Its work typically occurs before or during pre-seed and early seed stages, focusing on building initial teams, developing scientific platforms, and preparing companies for external fundraising. 
  
  

• Once companies are formed and achieve early milestones, follow-on funding often comes from Foresite Capital’s broader venture funds or through syndication with other VCs as they scale. 
  
  

• Foresite Labs itself does not publicly list standardized check sizes like a traditional VC — the core “investment” is talent, platform support, and incubation capital to launch companies. 
  
  
• In **2022, Foresite Capital raised a dedicated $173 million fund specifically to finance companies incubated through Foresite Labs. That vehicle supports startups as they scale beyond formation. 
  
  

• There are no publicly advertised fixed equity terms for companies formed in the Foresite Labs incubation process.
  
  
• Equity and ownership are typically structured as part of the company formation and subsequent funding agreements, reflecting contributions of capital, IP, and team composition negotiated per startup.
  
  

• Early-stage ownership is established at formation or at initial capital raises when companies transition outside the core incubator.
  
  
• Structured instruments may include:
  
  
  • Priced equity in seed financing
    
    
  • Convertible instruments such as SAFEs or notes, depending on deal and investor syndicate
    
    
• Because Foresite Labs functions as a venture formation vehicle and incubator, equity outcomes vary across companies rather than following a fixed pattern.
  
  

• Foresite Labs does not publicly list a traditional open “application portal”; rather, it sources founders and scientific teams through:
  
  
  • Active recruitment of scientists, entrepreneurs, and researchers aligned to its mission
    
    
  • Internal ideation and data-driven project discovery
    
    
  • Referrals and partnerships with scientific / healthcare communities
    
    

• Engagement often involves exploratory discussions with the Foresite Labs leadership team to shape ideas into investible company blueprints, rather than a typical accelerator cohort model.
  
  

Eligibility

• Precision medicine
  
  
• Biotechnology platforms
  
  
• AI and data science applied to drug discovery, genomics, and biological research
  
  
• Healthcare services that integrate advanced analytics or machine learning with scientific discovery
  
  

• Based in San Francisco, California, and Boston, Massachusetts — while companies formed have U.S. roots, ventures can scale globally. 
  
  

• Idea through pre-seed formation: Foresite Labs builds companies from concept.
  
  
• Post-formation, companies move toward seed and later rounds with typical venture investors.
  
  

• Founders, researchers, and entrepreneurs with deep domain expertise in:
  
  
  • Computational biology
    
    
  • Genomics
    
    
  • AI/ML for drug discovery
    
    
  • Healthcare technology
    
    

Process

What an Applicant can Obtain